Mark Manfredi
Founder chez IKENA ONCOLOGY, INC.
Fortune : - $ au 31/03/2024
Postes actifs de Mark Manfredi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IKENA ONCOLOGY, INC. | Director/Board Member | 01/12/2017 | - |
| Chief Executive Officer | 01/12/2017 | - | |
| Founder | 01/02/2016 | - | |
| President | 01/12/2017 | - | |
| Chief Tech/Sci/R&D Officer | 01/03/2016 | 01/12/2017 | |
Amplify Medicines, Inc.
 Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The private company is based in Boston, MA. The company was founded by Peter Smith. | President | - | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - | - |
Historique de carrière de Mark Manfredi
Anciens postes connus de Mark Manfredi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Raze Therapeutics, Inc.
 Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/04/2015 | 01/04/2016 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Formation de Mark Manfredi
| University of Rhode Island | Undergraduate Degree |
| Boston College | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Japon | 2 |
Opérationnelle
| President | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Raze Therapeutics, Inc.
Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Health Technology |
Amplify Medicines, Inc.
Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The private company is based in Boston, MA. The company was founded by Peter Smith. | Health Technology |
- Bourse
- Insiders
- Mark Manfredi
- Expérience
